Figure 3.
Figure 3. Characteristics of B-cell depletion and kinetics of B-cell recovery. Flow cytometric analysis of PB, spleen, BM, and LN before and 12 days after 2 injections with CD22/cal demonstrating that CD22/cal is not cytotoxic for (A) CD3+ T cells and (B) Gr-1+ myeloid cells. (C) Flow cytometric analysis showing the kinetics of CD22+ B-cell recovery in BM samples. (D) Flow cytometric analysis demonstrating that there is complete recovery of CD22+ B cells in PB, spleen, BM, and LNs 50 days after the first injection with CD22/cal. Three mice per group were analyzed; representative data from one mouse are shown.

Characteristics of B-cell depletion and kinetics of B-cell recovery. Flow cytometric analysis of PB, spleen, BM, and LN before and 12 days after 2 injections with CD22/cal demonstrating that CD22/cal is not cytotoxic for (A) CD3+ T cells and (B) Gr-1+ myeloid cells. (C) Flow cytometric analysis showing the kinetics of CD22+ B-cell recovery in BM samples. (D) Flow cytometric analysis demonstrating that there is complete recovery of CD22+ B cells in PB, spleen, BM, and LNs 50 days after the first injection with CD22/cal. Three mice per group were analyzed; representative data from one mouse are shown.

Close Modal

or Create an Account

Close Modal
Close Modal